Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria.

International journal of endocrinology·2020

Same author

Immune checkpoint inhibitors in mCRPC - rationales, challenges and perspectives.

Oncoimmunology·2019

Same author

Hematopoiesis is prognostic for toxicity and survival of <sup>223</sup>Radium treatment in patients with metastatic castration-resistant prostate cancer.

Hellenic journal of nuclear medicine·2018

Same author

32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016.

EJNMMI research·2016

Same author

[Protection of the unborn child in diagnostic and interventional radiological procedures].

Der Radiologe·2015

Same author

Quality of life aspects in the management of thyroid cancer.

Oral oncology·2015

Search research articles

Related Experiment Video

Updated: Jul 4, 2026

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

A Practical Guide for the Production and PET/CT Imaging of ⁶⁸Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

Imaging of Primitive Neuroectodermal Tumor (PNET) by Technetium-99m Tetrofosmin.

G Karanikas¹, W Köstler, A Becherer

¹Departments of Nuclear Medicine and Internal Medicine I University of Vienna Vienna Austria.

|June 4, 2008

Summary

Technetium-99m (Tc-99m) tetrofosmin scintigraphy successfully visualized pelvic PNET (primitive neuroectodermal tumor) in a patient. This imaging technique may offer valuable supplementary data for PNET diagnosis and staging.

Related Experiment Videos

Last Updated: Jul 4, 2026

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

A Practical Guide for the Production and PET/CT Imaging of ⁶⁸Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

Area of Science:

Nuclear Medicine
Oncology
Radiology

Background:

Technetium-99m (Tc-99m) tetrofosmin is established for myocardial imaging.
Tc-99m tetrofosmin has demonstrated utility in detecting various tumors.
Limited data exists on Tc-99m tetrofosmin imaging for primitive neuroectodermal tumors (PNET).

Purpose of the Study:

To evaluate the efficacy of Tc-99m tetrofosmin scintigraphy in imaging pelvic primitive neuroectodermal tumors (PNET).
To assess if Tc-99m tetrofosmin can provide additional diagnostic information beyond conventional imaging for PNET.

Main Methods:

A case study involving a 21-year-old male patient with a pelvic PNET.
Tc-99m tetrofosmin scintigraphy was performed in conjunction with computed tomography (CT) and magnetic resonance imaging (MRI).

Main Results:

Tc-99m tetrofosmin scintigraphy successfully visualized gluteal and iliac tumor masses.
The scintigraphy findings correlated with results obtained from CT and MRI.

Conclusions:

Tc-99m tetrofosmin imaging shows potential as an adjunct to conventional radiological modalities for PNET diagnosis.
This technique may serve as a useful tool for restaging primary PNET.